您所在的位置:首页 新闻动态 学术讲座

学术讲座

达特茅斯学院(Dartmouth College)帅康应邀作报告

报告信息

题目:Effect Score Analysis in Randomized Controlled Trials with Survival Outcome

报告人: 帅康(Dartmouth College)

时 间: 2026年6月26日 (周五) 16:00-17:00

地 点: 阜成路校区教1楼401会议室

联系人:吴鹏(北京工商大学)

报告摘要

Practitioners (e.g, doctors) will usually report an Average Treatment Effect (ATE), which fails to reflect the clinical experience and expectation that differences in patient prognostic characteristics will lead to heterogeneous responses to therapy. This is characterized by the so-called heterogeneous treatment effect (HTE). It is also a key question of great interest in the presence of survival outcome. The presence of censored data complicates the analysis of HTE due to the inclusion of the censoring probability. The existing methods mainly focus on directly estimating the so-called conditional average treatment effect (CATE), which represents the treatment effect for individuals with the same characteristics. This will encounter practical difficulties with many covariates and small sample size. Inference of the heterogeneity using the estimated CATE will be a further problem due to the multiple testing issue and small samples for certain survived subpopulations.

In this paper, we propose a general approach based on the Neyman's repeated sampling framework and a pre-specified effect scoring rule, which can either be given in advance or estimated using the observed dataset. Using the effect score, we can further split the dataset into three subsets, with each estimating censoring probability, scoring rule and group average treatment effect (GATE). Then we conduct the test of homogeneous treatment effects across the groups and the rank-consistency of the proposed scoring rule, with valid confidence intervals being constructed. We further apply the cross-fitting technique to improve the estimation performance of the GATEs. The proposed method can be especially useful from the exploratory analysis perspective. Its validity does not rely on the specific form of scoring rule because the randomness comes solely from the treatment assignments, sampling variability of individuals and censoring probability estimation. Simulation experiments and an application are performed to illustrate our methodology.